Featured publications
Accelerating Characterization of Therapeutic Antibodies: A Comparative Assessment of icIEF-UV/MS and the Traditional Fractionation Workflow
July 28, 2025 | Journal of the American Society for Mass Spectrometry
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
November 2, 2023 | The New England Journal of Medicine
Multi-omic single cell sequencing: Overview and opportunities for kidney disease therapeutic development
April 5, 2023 | Frontiers in Molecular Biosciences
One-shot design of functional protein binders with BindCraft
August 27, 2025 | Nature
Accelerating Characterization of Therapeutic Antibodies: A Comparative Assessment of icIEF-UV/MS and the Traditional Fractionation Workflow
July 28, 2025 | Journal of the American Society for Mass Spectrometry
Burden of corticosteroid therapy in patients with immunoglobulin A nephropathy (IgAN): a systematic literature review
May 19, 2025 | BMC Nephrology
CKD progression, kidney failure, and mortality among US patients with IgA nephropathy
April 30, 2025 | Nephrology Dialysis Transplantation
State-of-Art Therapeutics in IgA Nephropathy
August 30, 2024 | Indian Journal of Nephrology
Minimal Change Disease and FSGS Are a Spectrum of a Single Disease within Immune-Mediated Nephrotic Syndrome
August 5, 2024 | Kidney360
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group
June 3, 2024 | Clinical Journal of the American Society of Nephrology
A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models
March 1, 2024 | The Journal of Clinical Investigation
A PRoliferation-Inducing Ligand (APRIL) in the Pathogenesis of Immunoglobulin A Nephropathy: A Review of the Evidence
November 4, 2023 | Journal of Clinical Medicine
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
November 2, 2023 | The New England Journal of Medicine
- 1
- 2
- 3
- …
- 6
- Next Page »